NCT03486821View on ClinicalTrials.gov

Ultra-hypofractionated Radiation in Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2026

Conditions
Early Stage Prostate Cancer
Interventions
RADIATION

Hypofractionated Radiation

All patients on this study will receive the same type of therapy, 2 treatment hypofractionated radiation therapy.

Trial Locations (1)

66190

University of Kansas Medical Center/ Cancer Center, Kansas City

All Listed Sponsors
lead

University of Kansas Medical Center

OTHER

NCT03486821 - Ultra-hypofractionated Radiation in Prostate Cancer | Biotech Hunter | Biotech Hunter